Organisation
Hematology
Current researchers
1 - 10 of 18 results
- Fatema Afennas (Member)
- Veerle Beckers (Member)
- Charlotte Caron (Member)
- Ludwine Antoinette Claeys (Member)
- Ann De Becker (Member)
- Nathan De Beule (Member)
- Inke De Haes (Member)
- Sylvia Faict (Member)
- Karel Fostier (Member)
- Kristin Jochmans (Member)
Projects
1 - 1 of 1
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
Publications
21 - 30 of 79
- Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.(2021)
Authors: Anke Delie, Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure, Frédéric Baron, Dimitri Breems, Ann De Becker, Carlos Graux, P. Lewalle, et al.
Pages: 500-508 - Measuring antenatal care use in Europe(2017)
Authors: Katrien Beeckman, Lucy Frith, Helga Gottfreðsdóttir, Annette Bernloehr
Pages: 583-590 - Assessing the performance of maternity care in Europe(2015)
Authors: Ramón Escuriet, Joanna White, Katrien Beeckman, Lucy Frith, Fatima Leon-Larios, Christine Loytved, Ans Luyben, Marlene Sinclair, Edwin van Teijlingen
- Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation(2018)
Authors: Willem Staels, Yannick Verdonck, Yves Heremans, Gunter Leuckx, Sofie De Groef, Carlo Heirman, Eelco De Koning, Conny Gysemans, Kris Thielemans, L Baeyens, et al.
Pages: 1804-1810 - Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Authors: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pages: 112-121 - Predictors of late initiation for prenatal care in a metropolitan region in Belgium. A cohort study(2015)
Authors: Maaike Fobelets, Katrien Beeckman, Annemarie Hoogewys, Mieke Embo, Ronald Buyl, Koen Putman
Pages: 648-654 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Authors: Julia Katharina Schwarze, Gil Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, B Neyns
Pages: 1-16 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, Gil Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13 - Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma(2023)
Authors: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Henri Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, et al.
Pages: 1172-1177 - Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Authors: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pages: 249-255